We're in the business of helping you make human connections.
ICU Medical has consistently provided you with clinical innovations that help solve real-world challenges.
With the acquisition of Hospira Infusion Systems in 2017 and Smiths Medical in 2022, we are now a global market leader with a complete line of clinically essential IV therapy and high-value critical care products for hospital, alternate site and home care settings.
We're ready to bring you consistent quality, innovation, and value in more areas than ever.
100% committed to meeting your clinical needs. Now and in the future.
At ICU Medical, we're committed to controlling our quality from product concept, design, development, and testing - to manufacturing, sterilisation, and distribution. Everything we do is focused on providing you with the highest quality products, service, and support.